These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 7554032)
1. Transgenic and gene knockout mice in cancer research. Viney JL Cancer Metastasis Rev; 1995 Jun; 14(2):77-90. PubMed ID: 7554032 [TBL] [Abstract][Full Text] [Related]
2. Modeling disease in the mouse: lessons from DNA damage response and cell cycle control genes. Adelman CA; Petrini JH; Attwooll CL J Cell Biochem; 2006 Feb; 97(3):459-73. PubMed ID: 16288461 [TBL] [Abstract][Full Text] [Related]
3. Transgenic and knockout models for studying diseases of the immune system. Viney JL Curr Opin Genet Dev; 1994 Jun; 4(3):461-5. PubMed ID: 7919925 [TBL] [Abstract][Full Text] [Related]
4. Transgenic and knockout mouse models clarify pituitary development, function and disease. Asa SL Brain Pathol; 2001 Jul; 11(3):371-84. PubMed ID: 11414478 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways controlling the switch between keratinocyte growth and differentiation. Dotto GP Crit Rev Oral Biol Med; 1999; 10(4):442-57. PubMed ID: 10634582 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Kirma N; Gill K; Mandava U; Tekmal RR Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746 [TBL] [Abstract][Full Text] [Related]
7. Skin cancer and transgenic mice. Zinkel S; Fuchs E Semin Cancer Biol; 1994 Feb; 5(1):77-90. PubMed ID: 8186391 [TBL] [Abstract][Full Text] [Related]
9. Gene knockout and transgenic technologies in risk assessment: the next generation. Rosenberg MP Mol Carcinog; 1997 Nov; 20(3):262-74. PubMed ID: 9397186 [TBL] [Abstract][Full Text] [Related]
10. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. Dailey L; Laplantine E; Priore R; Basilico C J Cell Biol; 2003 Jun; 161(6):1053-66. PubMed ID: 12821644 [TBL] [Abstract][Full Text] [Related]
11. Growth factors in breast cancer: mitogenesis to transformation. Dickson RB; Johnson MD; Bano M; Shi E; Kurebayashi J; Ziff B; Martinez-Lacaci I; Amundadottir LT; Lippman ME J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):69-78. PubMed ID: 1525068 [TBL] [Abstract][Full Text] [Related]
18. Transgenic mice and squamous multistage skin carcinogenesis. Brown K; Balmain A Cancer Metastasis Rev; 1995 Jun; 14(2):113-24. PubMed ID: 7554029 [TBL] [Abstract][Full Text] [Related]
19. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. Merlino G Semin Cancer Biol; 1994 Feb; 5(1):13-20. PubMed ID: 8186384 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]